Subscribe
Subscribe to IHE
Institute of Health Economics logo
My IHE Login
  • About IHE
    • About
    • History
    • Board of Directors
    • Corporate Reports
    • Partnerships & Affiliations
    • Staff Directory
    • Careers and Awards
    • Privacy Policy
  • Research & Programs
    • Health Technology Assessment
    • Health Economics
    • Industry Partnerships
    • Knowledge Transfer
    • Research Methodology Development
  • Publications
  • Events
    • Upcoming Events
    • Past Events
  • News
    • News
  • Contract Our Services
Home / Advanced Search

Advanced Search

Result Type

  • Publications
    • All Publications
    • Books
    • Consensus Statements
    • Economic Reports
    • Health Technology Assessments /
      Systematic Reviews
    • Health Topic Overviews / Scoping Reviews
    • HTA Policy
    • Journal Articles
    • Methodology Papers
    • Overview of Systematic Reviews
    • Rapid Reviews
    • Statistics Handbooks
    • Summary Reports
  • Other Resources
    • All Resources
    • Backgrounders
    • Clinical Practice Guidelines
    • Clinical Tools
    • Event Proceedings
    • Patient Resources
    • Presentations
    • Programs
  • News/Events
  • General Content

Years

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 1996-2013
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
    • 1998
    • 1997
    • 1996

Topics

  • Cancer
  • Chronic Diseases / Disorders
  • Community Health Centres
  • COVID-19
  • Diabetes
  • Diagnosis
  • Fetal Alcohol Spectrum Disorder (FASD)
  • Health Economics / Healthcare Costs
  • Health Measurement Tools
  • Health Policy
  • Health Technology Assessment
  • Health Topic Overviews
  • Healthcare Services
  • Infectious Diseases
  • Maternal and Child Health
  • Mental Health
  • Nurse Practitioners
  • Other
  • Pharmaceuticals
  • Prevention
  • Primary Care
  • Quality of Life
  • Scoping Reviews
  • Screening
  • Surveillance
  • Telehealth
  • Therapy

Authors

  • Akpinar, Ilke
  • Bond, Ken
  • Brown, Jasmine
  • Chojecki, Dagmara
  • Corabian, Paula
  • Guo, Bing
  • Institute of Health Economics, IHE
  • McCabe, Christopher
  • Moga, Carmen
  • Palfrey, Dan
  • Pollock, Michelle
  • Round, Jeff
  • Seida, Jennifer
  • Sproule, John
  • Sutton, Andrew J.
  • Tjosvold, Lisa
  • Tran, Dat
  • Warkentin, Lindsey
  • Wright, Erica
  • Yan, Charles

The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.

If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!

Refine your search by clicking filters to the left.

Results for: Ilke Akpinar

Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada

September 26, 2019

| Dat Tran, Ilke Akpinar, Irvin Mayers, Tatiana Makhinova, Philip Jacobs

The objective of this study, published in the International Journal of Chronic Obstructive Pulmonary Disease, was to describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada.

The Costs of Industry-Sponsored Drug Trials in Canada

July 10, 2019

| Dat Tran, Ilke Akpinar, Philip Jacobs

This study, published in PharmacoEconomics – Open, reports exploratory analysis of the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. The costs of industry-sponsored drug CTs completed in 2016 were Can$2.1 billion. In addition to the creation of knowledge, these trials play an important role in alleviating the healthcare cost burden…

Publicly funded clinical research in Canada

July 02, 2019

| Ilke Akpinar, Dat Tran, Philip Jacobs

Clinical research is funded by industry, governments, charities, and hospitals. It is important to know the economic commitment of the various funding bodies, but until now there has been no national source available which provides these data. We surveyed the major funders to provide such a measure. There is evidence that government and charity funding of medical research is a…

The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials

November 20, 2017

| Dat Tran, Ilke Akpinar, Richard Fedorak, Egon Jonsson, John Mackey, Lawrence Richer, Philip Jacobs

Purpose: In pharmaceutical clinical trials, industrial sponsors pay for study drugs and related healthcare services. We conducted a study to determine industry’s economic contribution of these trials to the Alberta healthcare system. Authors and Affiliations: Dat T. Tran1,2; Ilke Akpinar2 ; Richard N. Fedorak3 ; Egon Jonsson2 ; John R. Mackey4 ; Lawrence Richer5 ; Philip…

Benefit of adjunct universal rectal screening for Chlamydia genital infections in women attending Canadian sexually transmitted infection clinics

May 23, 2017

| Thanh Nguyen, Ilke Akpinar, Jennifer Gratrix, Sabrina Plitt, Petra Smyczek, Ron Read, Philip Jacobs, Tom Wong, Ameeta E Singh

Adding universal rectal screening to urogenital screening should positively impact rectal Chlamydia trachomatis (CT) incidence in affected populations. A dynamic Markov model was used to evaluate costs and outcomes of three rectal CT screening strategies among women attending sexually transmitted infection clinics in Alberta, Canada: universal urogenital-only screening (UG-only),…

Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review

November 08, 2016

| Ilke Akpinar, Philip Jacobs, Tien Dat Tran

Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast.

Medical Device Prices in Economic Evaluations.

May 20, 2015

| Ilke Akpinar, Philip Jacobs, Don Husereau

  Objectives: Economic evaluations, although not formally used in purchasing decisions for medical devices in Canada, are still being conducted and published. The aim of this study was to examine the way that prices have been included in Canadian economic evaluations of medical devices.

  • Site Map
  • Privacy Policy
  • Contact Us & Subscribe
  • Home

Copyright © 2021 Institute of Health Economics

Institute of Health Economics 1200 10405 Jasper Avenue Edmonton, AB, Canada T5J 3N4

P: (1) 780.448.4881 F: (1) 780.448.0018
Email: [email protected]

Links

Canada

United States

United Kingdom

Other International

Journals

Health Economics Resources

Free Database Access

Never miss an update!

Subscribe to IHE